Atlas Trials

Study of CPX-351 (VYXEOS) in Individuals < 22 Years With Secondary Myeloid Neoplasms

Clinical trial NCT05656248 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05656248
Sponsor
St. Jude Children's Research Hospital
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Myeloid Neoplasm
Start date
2023-01-17
Primary completion
2025-08-28
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.